Neonatal Hyperbilirubinemia Clinical Trial
Official title:
Dose-response Relationship of Phototherapy for Hyperbilirubinaemia Using Diodes: is There a "Saturation Point"?
Background: Using light emitting diodes (LED's) during conventional phototherapy it is
possible to reduce the distance from light source to infant, thereby increasing light
irradiance.
Objective: To examine the relation between light irradiance and the rate of decrease in
total serum bilirubin concentration (TsB) and to see if the investigators can identify a
"saturation point", i.e. an irradiation level above which there is no further decrease in
TsB.
Design: Prospective randomised study. Setting: Neonatal Intensive Care Unit, Pediatric
Department, Aalborg Hospital, Aarhus University Hospital, Denmark.
Material and method: 151 infants with gestational age ≥ 33 weeks and uncomplicated
hyperbilirubinaemia are randomised to one of 4 different distances from phototherapy device
to mattress (20, 29, 38 and 47 cm). TsB is measured before and after 24 hours of
phototherapy and irradiance every 8th hour. Main outcome measure is 24 hours decrease of TsB
expressed in percent (∆ TsB0-24 (%)).
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06186349 -
The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
|
||
Recruiting |
NCT04369313 -
Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers
|
N/A | |
Not yet recruiting |
NCT04585828 -
Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy
|
N/A | |
Completed |
NCT02927093 -
Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life
|
N/A | |
Unknown status |
NCT01340339 -
Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
|
Phase 4 | |
Completed |
NCT02033096 -
Observational Follow-up of Participants From Clinical Trial 64,185-202 (NCT00850993)
|
||
Recruiting |
NCT04218318 -
Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
|
N/A | |
Active, not recruiting |
NCT02602301 -
The Effect of Intravenous Oxytocin Infusion Using Different Diluents on Neonatal Bilirubin & Sodium Levels
|
Phase 4 | |
Completed |
NCT00801619 -
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
|
N/A | |
Active, not recruiting |
NCT05343403 -
Parental Participation on the Neonatal Ward - the neoPARTNER Study
|
||
Completed |
NCT03880591 -
Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
|
||
Completed |
NCT01599611 -
Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study
|
N/A | |
Recruiting |
NCT06399146 -
Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
|
N/A | |
Completed |
NCT06018012 -
MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates
|
||
Completed |
NCT03536078 -
Home Phototherapy for Term Newborns With Icterus
|
N/A | |
Withdrawn |
NCT00917007 -
Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
|
||
Recruiting |
NCT00154960 -
Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.
|
N/A | |
Recruiting |
NCT02594904 -
Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
|
Phase 4 | |
Completed |
NCT01746511 -
Glycerin Suppositories to Reduce Jaundice in Premature Infants
|
N/A | |
Completed |
NCT02361788 -
Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)
|